Skip to main content
Clinical Trials/NCT07112950
NCT07112950Not yet recruitingNot Applicable

The Effect of Press Needle Acupuncture on Pain Reduction and Quality of Life Improvement in Lung Cancer Patients

Indonesia University1 site in 1 country32 target enrollmentStarted: August 11, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
32
Locations
1
Primary Endpoint
Visual Analogue Scale (VAS) for Pain

Study Overview

Brief Summary

The purpose of this clinical trial is to evaluate the effect of press needle acupuncture on pain management and quality of life improvement in patients with lung cancer.

The main question this study aims to answer is:

Does press needle acupuncture, when combined with standard therapy, provide better pain relief and quality of life improvement in lung cancer patients compared to standard therapy alone?

Researchers will compare press needle acupuncture to sham acupuncture to determine whether press needle acupuncture is more effective in reducing pain and improving quality of life.

Participants will:

Receive either press needle acupuncture or sham press needle acupuncture for 7 days

Visit the clinic once a week for examination and evaluation

Record improvements in pain intensity in a pain diary and assess quality of life using a quality of life questionnaire

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Masking Description

the participants and the outcome assessors will be blinded to group allocation

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with a confirmed diagnosis of lung cancer through histopathology or radiology.
  • •Lung cancer patients aged over 18 years.
  • •Stage III-IV lung cancer patients receiving therapy at Dr. Cipto Mangunkusumo National General Hospital (RSUPN) and Tangerang District General Hospital (RSUD Kabupaten Tangerang).
  • •Patients with a VAS score >10 mm for baseline pain and >40 mm during breakthrough pain.
  • •Willing to participate in the study until completion by signing the informed consent form.

Exclusion Criteria

  • •Lung cancer patients with deteriorating general condition.
  • •Presence of wounds or infections at the press needle insertion site.
  • •History of allergy to stainless steel materials.
  • •Patients with blood clotting disorders: platelet count <50,000/μL, ANC <1000/mm³, or patients undergoing anticoagulant therapy with INR >2.142.

Arms & Interventions

Intervention Group

Experimental

The press needle acupuncture and standart therapy

Intervention: Press Needle Acupuncture and standart therapy (Device)

Control Group

Sham Comparator

The sham press needle acupuncture and standart therapy

Intervention: Press Needle Acupuncture and standart therapy (Device)

Outcomes

Primary Outcomes

Visual Analogue Scale (VAS) for Pain

Time Frame: Before therapy, Day 1, Day 3, Day 7, and Day 14

Pain intensity will be measured using the Visual Analogue Scale (VAS), which consists of a horizontal or vertical line 10 cm (100 mm) in length, representing a continuum of pain intensity from: 0 = No pain at all 10 = Worst imaginable pain

Secondary Outcomes

  • Functional Assessment of Cancer Therapy - Lung (FACT-L)(Before therapy, Day 7, and Day 14)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yuanti Yunus Konda

MD

Indonesia University

Study Sites (1)

Loading locations...

Similar Trials